Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma.
Garg M, Kanojia D, Mayakonda A, Said JW, Doan NB, Chien W, Ganesan TS, Chuang LS, Venkatachalam N, Baloglu E, Shacham S, Kauffman M, Koeffler HP.
Garg M, et al.
Oncotarget. 2017 Jan 31;8(5):7521-7532. doi: 10.18632/oncotarget.13485.
Oncotarget. 2017.
PMID: 27893412
Free PMC article.